Adverse events56

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 56

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anemia	Blood and lymphatic system disorders	Treatment (Trebananib)	3	16	4
other	Mucositis oral	Gastrointestinal disorders	Treatment (Trebananib)	1	16	1
other	Nausea	Gastrointestinal disorders	Treatment (Trebananib)	2	16	2
other	Edema face	General disorders	Treatment (Trebananib)	2	16	6
other	Edema limbs	General disorders	Treatment (Trebananib)	7	16	19
other	Fatigue	General disorders	Treatment (Trebananib)	3	16	3
other	Pain	General disorders	Treatment (Trebananib)	1	16	1
other	Allergic reaction	Immune system disorders	Treatment (Trebananib)	1	16	1
other	Infections and infestations - Other, specify	Infections and infestations	Treatment (Trebananib)	1	16	1
other	Urinary tract infection	Infections and infestations	Treatment (Trebananib)	1	16	1
other	Activated partial thromboplastin time prolonged	Investigations	Treatment (Trebananib)	2	16	6
other	Alanine aminotransferase increased	Investigations	Treatment (Trebananib)	1	16	1
other	Alkaline phosphatase increased	Investigations	Treatment (Trebananib)	2	16	3
other	Aspartate aminotransferase increased	Investigations	Treatment (Trebananib)	3	16	3
other	Blood bilirubin increased	Investigations	Treatment (Trebananib)	1	16	1
other	CD4 lymphocytes decreased	Investigations	Treatment (Trebananib)	1	16	3
other	Creatinine increased	Investigations	Treatment (Trebananib)	1	16	2
other	INR increased	Investigations	Treatment (Trebananib)	2	16	2
other	Lymphocyte count decreased	Investigations	Treatment (Trebananib)	3	16	5
other	Platelet count decreased	Investigations	Treatment (Trebananib)	2	16	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01623869/events